Image Caption: Proteomic alterations in post-NACT OCPM tissues. Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the ...
SB221: A proof-of-concept study to assess the combination of SON-1010 (IL12-FHAB) and atezolizumab in patients with platinum-resistant ovarian cancer. This is an ASCO Meeting Abstract from the 2024 ...
Staging means finding out how far ovarian cancer has spread in your body. Physicians group ovarian cancer into stages I (1) through IV (4), with stage I being the least advanced and stage IV being the ...
Oncoinvent, a clinical-stage radiopharmaceutical company developing Radspherin®, a receptor-independent alpha-emitting therapy to eradicate cancer cells in the abdominal cavity after surgery with a ...
The Wistar Institute's Nan Zhang, Ph.D., assistant professor in the Ellen and Ronald Caplan Cancer Center's Molecular and Cellular Oncogenesis Program, and colleagues have discovered a new approach to ...
Effect of nilotinib on cell proliferation and migration of ovarian cancer cells alone and in combination with standard chemotherapy. Background: Advances in laparoscopic surgery have allowed a ...
The preferred neoadjuvant chemotherapy regimen is a platinum-taxane doublet. The American Society of Clinical Oncology (ASCO) has updated its guidelines on neoadjuvant chemotherapy use in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results